Evidence of basal ganglia involvement in mask-induced inhibition
Objective: This study evaluates if basal ganglia inhibitory projections to the superior colliculus are involved in the saccadic mask inhibition phenomenon. Background: Saccadic mask inhibition is…Gender Disparities in Daytime Sleepiness Among Hispanic Individuals with Parkinson’s Disease: A Cross-Sectional Study
Objective: Explore gender-based disparities in daytime sleepiness among Hispanic individuals with Parkinson's disease (PD). Background: PD is a neurodegenerative disorder with various motor and non-motor…Designing a Device for Real-time Monitoring and Digital Integration of Non-motor Symptoms
Objective: This study aims to prototype a measurement device for the continuous assessment of non-motor symptoms like pain in Parkinson's disease (PD) and their seamless…Fatigue in Parkinson’s Disease: Prevalence and Risk Factors
Objective: To determine the prevalence of fatigue among people with PD (PwP) in comparison to the general population and to identify fatigue associated factors. Background:…Age of Onset and Non-Motor Symptoms in Early Parkinson’s Disease: A Data-Analysis Study Based on the Fox Insight Cohort
Objective: To compare late-onset and early-onset patients with Parkinson’s Disease (PD) in how they differ from their matched healthy controls (HC) regarding the presence of…Gastrointestinal Dysbiosis and Clinical Outcomes in Parkinson’s Disease
Objective: To evaluate whether patients with PD exhibit 1) a bloom in sulfate-reducing bacteria based on the detection of hydrogen-sulfide (H2S) during lactulose breath testing…Examining the Effects of Deep Brain Stimulation on Speech in Parkinson’s Disease
Objective: The current goal is to use pilot data to explain speech changes in patients with Parkinson’s disease (PD) who have Deep Brain Stimulation (DBS)…Gender Disparities in Depressive Symptoms among Hispanic Parkinson’s Disease Patients: A Cross-Sectional Study
Objective: Investigate gender-specific disparities in depressive symptoms among Hispanic Parkinson's disease (PD) patients using Center for Epidemiologic Studies Depression Scale (CES-D) scores. Background: PD not…Dopamine agonist use and psychotic symptoms in patients with Parkinson’s disease.
Objective: To describe the clinical and demographic characteristics of patients with PDP and their relationship with the use of DAs. Background: Parkinson’s Disease Psychosis (PDP)…The Neuroprotective Effects of Rolipram, a Selective Phosphodiesterase IV Inhibitor, on Parkinson’s Disease in Rat Models: A Pharmacological Exploration in both In vivo and In vitro Settings
Objective: Our research sought to unravel the pharmacological effects and mechanisms of action of Rolipram through both in vivo and in vitro experimentation in models…
- « Previous Page
- 1
- …
- 147
- 148
- 149
- 150
- 151
- …
- 181
- Next Page »